| Description |
1 online resource (1 PDF file (xx, 83 pages)) : illustrations |
| Series |
Consensus study report.
|
| Summary |
The United States is facing an opioid use disorder epidemic with opioid overdoses killing 47,000 people in the U.S. in 2017. The past three decades have witnessed a significant increase in the prescribing of opioids for pain, based on the belief that patients were being undertreated for their pain, coupled with a widespread misunderstanding of the addictive properties of opioids. This increase in prescribing of opioids also saw a parallel increase in addiction and overdose. In an effort to address this ongoing epidemic of opioid misuse, policy and regulatory changes have been enacted that have served to limit the availability of prescription opioids for pain management. Overlooked amid the intense focus on efforts to end the opioid use disorder epidemic is the perspective of clinicians who are experiencing a significant amount of daily tension as opioid regulations and restrictions have limited their ability to treat the pain of their patients facing serious illness. Increased public and clinician scrutiny of opioid use has resulted in patients with serious illness facing stigma and other challenges when filling prescriptions for their pain medications or obtaining the prescription in the first place. Thus clinicians, patients, and their families are caught between the responses to the opioid use disorder epidemic and the need to manage pain related to serious illness. The National Academies of Sciences, Engineering, and Medicine sponsored a workshop on November 29, 2018, to examine these unintended consequences of the responses to the opioid use disorder epidemic for patients, families, communities, and clinicians, and to consider potential policy opportunities to address them. This publication summarizes the presentations and discussions from the workshop |
| Bibliography |
Includes bibliographical references |
| Notes |
This activity was supported by Aetna Inc., Altarum Institute, American Academy of Hospice and Palliative Medicine, American Cancer Society, American Geriatrics Society, Anthem Inc., Ascension Health, Association of Professional Chaplains, Association of Rehabilitation Nurses, Blue Cross Blue Shield Association, Blue Cross Blue Shield of Massachusetts, Blue Cross and Blue Shield of North Carolina, Bristol-Myers Squibb, The California State University Institute for Palliative Care, Cambia Health Solutions, Cedars-Sinai Health System, Center to Advance Palliative Care, Centers for Medicare & Medicaid Services, Coalition to Transform Advanced Care, Excellus BlueCross BlueShield, Federation of American Hospitals, The Greenwall Foundation, The John A. Hartford Foundation, Hospice and Palliative Nurses Association, Kaiser Permanente, Susan G. Komen, Gordon and Betty Moore Foundation, National Coalition for Hospice and Palliative Care, National Hospice and Palliative Care Organization, National Palliative Care Research Center, National Patient Advocate Foundation, National Quality Forum, The New York Academy of Medicine, Oncology Nursing Society, Patient-Centered Outcomes Research Institute, Social Work Hospice and Palliative Care Network, Supportive Care Coalition, and the National Academy of Medicine. The MAYDAY Fund also provided support for this project. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project |
|
Online resource; title from PDF title page (viewed November 1, 2019) |
| Subject |
Pain -- Treatment -- United States -- Congresses
|
|
Opioid abuse -- Treatment -- United States
|
|
Opioid abuse -- United States -- Prevention
|
|
Drugs -- Prescribing -- United States -- Congresses
|
|
Comorbidity -- United States -- Congresses
|
|
Chronically ill -- Care -- United States -- Congresses
|
|
Chronic diseases -- United States
|
|
Opioid-Related Disorders -- epidemiology
|
|
Pain Management
|
|
Chronic diseases.
|
|
Chronically ill -- Care.
|
|
Comorbidity.
|
|
Drugs -- Prescribing.
|
|
Opioid abuse -- Treatment.
|
|
Pain -- Treatment.
|
|
United States |
|
United States.
|
| Genre/Form |
Conference papers and proceedings.
|
|
Conference papers and proceedings.
|
|
Actes de congrès.
|
| Form |
Electronic book
|
| Author |
Olchefske, India, rapporteur
|
|
Alper, Joe, rapporteur
|
|
National Academies of Sciences, Engineering, and Medicine (U.S.). Roundtable on Quality Care for People with Serious Illness, issuing body, sponsoring body.
|
|
Pain Management for People with Serious Illness in the Context of the Opioid Use Disorder Epidemic (Workshop) (2018 : Washington, D.C.)
|
| ISBN |
9780309492232 |
|
0309492238 |
|
9780309492249 |
|
0309492246 |
|
9780309492263 |
|
0309492262 |
|
